State of the art Manufacturing

Astellas Pharmaceutical manufacturing facility in Peshawar, Pakistan spread across 52,000 sqf. with a covered area of about 40,000 sqf; began production in 2006, and is at present fully operational. This manufacturing facility complies with the most up-to-date international pharmaceutical industry standards and is equipped with world-class HVAC installations. There are segregated areas for the production of quality medicines from a diverse range of therapeutic segments, including a dedicated area for cephalosporins.

Production Capacity

General and Antibiotic

  • Tablets: 1 Million / day
  • Liquid Syrup: 120,000 Bottles / day
  • Dry Suspension: 30,000 Bottles / day
  • Capsules (General): 1 Million / day
  • Impule: 200,000 / day
  • Infusion: 20,000 / day

Dedicated Cephalosporin

  • Dry Vial Injection: 120,000 / day
  • Capsule: 500,000 / day
  • Dry Suspension: 50,000 / day